methylprednisolone has been researched along with pamidronate in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berdon, W; Bilezikian, JP; Gertner, JM; Harbison, M; Horlick, M; Levine, LS; Levy, J; Oberfield, SE; Thearle, M | 1 |
| Geusens, P; Menten, J; van der Linden, S; Vanhoof, J; Vosse, D | 1 |
| Cho, BS; Kim, SD | 1 |
| Adamopoulos, IE; Athanasou, NA; Edwards, JR; Ferguson, DJ; Wordsworth, PB | 1 |
| Ahmad, I; Garg, S; Kapoor, S; Malaviya, AN; Raja, RR | 1 |
| Chakravarty, A; Chogle, AR; Mishra, H | 1 |
| Abdessemed, A; Haddouche, A; Ladjouze-Rezig, A; Slimani, S | 1 |
1 review(s) available for methylprednisolone and pamidronate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for methylprednisolone and pamidronate
| Article | Year |
|---|---|
Pamidronate therapy for preventing steroid-induced osteoporosis in children with nephropathy.
Topics: Bone Density Conservation Agents; Child; Diphosphonates; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Nephrotic Syndrome; Osteoporosis; Pamidronate; Prospective Studies | 2006 |
A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
Topics: Adolescent; Adult; Antirheumatic Agents; Bone Density Conservation Agents; Diphosphonates; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged; Pamidronate; Spondylitis, Ankylosing; Sulfasalazine | 2007 |
8 other study(ies) available for methylprednisolone and pamidronate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Osteoporosis: an unusual presentation of childhood Crohn's disease.
Topics: Alkaline Phosphatase; Anti-Inflammatory Agents; Child; Crohn Disease; Diphosphonates; Humans; Jews; Lumbar Vertebrae; Male; Methylprednisolone; Osteoporosis; Pamidronate; Radiography; Spine; Thoracic Vertebrae | 2000 |
Recovery from severe glucocorticoid-induced osteoporosis in an adolescent boy.
Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Bone Density; Brain Stem Neoplasms; Diphosphonates; Glucocorticoids; Humans; Low Back Pain; Male; Mesencephalon; Methylprednisolone; Osteoporosis; Pamidronate; Spinal Fractures | 2001 |
Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
Topics: Adult; Anti-Inflammatory Agents; Arthritis; Bone Resorption; Carrier Proteins; Cell Differentiation; Cells, Cultured; Cytokines; Diphosphonates; Glycoproteins; Histiocytosis, Non-Langerhans-Cell; Humans; Immunohistochemistry; Leukocytes, Mononuclear; Macrophages; Male; Membrane Glycoproteins; Methylprednisolone; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Osteoclasts; Osteoprotegerin; Pamidronate; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Skin Diseases; Synovial Fluid; Tumor Necrosis Factor-alpha | 2006 |
A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Antirheumatic Agents; Diphosphonates; Humans; Methotrexate; Methylprednisolone; Pamidronate; Spondylitis, Ankylosing; Sulfasalazine; Treatment Failure; Tumor Necrosis Factor-alpha | 2007 |
Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.
Topics: Adolescent; Bone Density Conservation Agents; Calcinosis; Calcium; Cholecalciferol; Dermatomyositis; Diphosphonates; Drug Therapy, Combination; Female; Humans; Methylprednisolone; Pamidronate; Radiography; Recovery of Function; Treatment Outcome | 2010 |